Jun
18
2010

Eurand Announces Data On Switching Cystic Fibrosis Patients With Exocrine Pancreatic Insufficiency From Unapproved PEPs To FDA-Approved ZENPEP(R)

Originally posted in Cystic Fibrosis News From Medical News Today

Eurand Pharmaceuticals, Inc., a subsidiary of global specialty pharmaceutical company Eurand N.V…

Written by Cystic Fibrosis News From Medical News Today in: Cystic Fibrosis |

No Comments

Comments are closed.

RSS feed for comments on this post.

Bookmark Us!

©Uncle & Drunken Crayfish Productions 2011 www.DrunkenCrayfish.com DrunkenCrayfish

Visit our NEW site at PocketBiker.com
PocketBiker.com Logo

 

TheBuckmaker.com Wordpress Themes | Hosting Provider, Mixed-Tape Free Music